37297968|t|Systemic Anti-Inflammatory Effects of Intravenous Lidocaine in Surgical Patients: A Systematic Review and Meta-Analysis.
37297968|a|There has recently been increasing evidence that the use of perioperative intravenous lidocaine infusion possesses analgesic, opioid-sparing and anti-inflammatory effects in surgical patients. Although opioid-sparing and analgesic properties have been strongly supported, the anti-inflammatory features are not well established in elective surgery. Therefore, the aim of this systematic review is to examine the effect of perioperative intravenous lidocaine infusion on postoperative anti-inflammatory status in patients undergoing elective surgery. A search strategy was created to identify suitable randomised clinical trials (RCTs) in PubMed, Scopus, Web of Science and Clinicaltrials.gov databases until January 2023. RCTs that evaluated the effect of intravenous lidocaine infusion, compared with placebo, on adult patients who underwent elective surgery, in inflammatory markers response were included. Exclusion criteria consisted of paediatric patients, animal studies, non-RCT methodology, intervention without intravenous lidocaine, inadequate control group, duplicated samples, ongoing studies and lack of any relevant clinical outcome measures. The following inflammatory markers-interleukin (IL)-6, tumour necrosis factor (TNF)-alpha, IL-1RA, IL-8, IL-10, C-reactive protein (CRP), IL-1, IL-1beta, interferon (IFN)-gamma, cortisol, IL-4, IL-17, high-mobility group protein B1 (HMGB1) and transforming growth factor (TGF)-beta-were evaluated as outcomes in this review. A total of 21 studies, including 1254 patients, were identified. Intravenous lidocaine infusion significantly reduced the change from IL-6 baseline levels at the end of surgery compared to a placebo (standardised mean difference [SMD]: -0.647, 95% confidence interval [CI]: -1.034 to -0.260). Usage of lidocaine was associated with a significant reduction in other postoperative pro-inflammatory markers, such as TNF-alpha, IL-1RA, IL-8, IL-17, HMGB-1 and CRP. There was no significant difference in other markers, such as IL-10, IL-1beta, IL-1, IFN-gamma, IL-4, TGF-beta and cortisol. This systematic review and meta-analysis provide support for the administration of perioperative intravenous lidocaine infusion as an anti-inflammatory strategy in elective surgery.
37297968	14	26	Inflammatory	Disease	MESH:D007249
37297968	50	59	Lidocaine	Chemical	MESH:D008012
37297968	72	80	Patients	Species	9606
37297968	207	216	lidocaine	Chemical	MESH:D008012
37297968	271	283	inflammatory	Disease	MESH:D007249
37297968	304	312	patients	Species	9606
37297968	402	414	inflammatory	Disease	MESH:D007249
37297968	569	578	lidocaine	Chemical	MESH:D008012
37297968	610	622	inflammatory	Disease	MESH:D007249
37297968	633	641	patients	Species	9606
37297968	889	898	lidocaine	Chemical	MESH:D008012
37297968	941	949	patients	Species	9606
37297968	985	997	inflammatory	Disease	MESH:D007249
37297968	1073	1081	patients	Species	9606
37297968	1153	1162	lidocaine	Chemical	MESH:D008012
37297968	1292	1304	inflammatory	Disease	MESH:D007249
37297968	1313	1331	interleukin (IL)-6	Gene	3569
37297968	1333	1367	tumour necrosis factor (TNF)-alpha	Gene	7124
37297968	1369	1375	IL-1RA	Gene	3557
37297968	1377	1381	IL-8	Gene	3576
37297968	1383	1388	IL-10	Gene	3586
37297968	1390	1408	C-reactive protein	Gene	1401
37297968	1410	1413	CRP	Gene	1401
37297968	1416	1420	IL-1	Gene	3553
37297968	1422	1430	IL-1beta	Gene	3553
37297968	1432	1454	interferon (IFN)-gamma	Gene	3458
37297968	1456	1464	cortisol	Chemical	MESH:D006854
37297968	1466	1470	IL-4	Gene	3565
37297968	1472	1477	IL-17	Gene	3605
37297968	1479	1509	high-mobility group protein B1	Gene	3146
37297968	1511	1516	HMGB1	Gene	3146
37297968	1522	1559	transforming growth factor (TGF)-beta	Gene	7040
37297968	1641	1649	patients	Species	9606
37297968	1680	1689	lidocaine	Chemical	MESH:D008012
37297968	1737	1741	IL-6	Gene	3569
37297968	1905	1914	lidocaine	Chemical	MESH:D008012
37297968	1986	1998	inflammatory	Disease	MESH:D007249
37297968	2016	2025	TNF-alpha	Gene	7124
37297968	2027	2033	IL-1RA	Gene	3557
37297968	2035	2039	IL-8	Gene	3576
37297968	2041	2046	IL-17	Gene	3605
37297968	2048	2054	HMGB-1	Gene	3146
37297968	2059	2062	CRP	Gene	1401
37297968	2126	2131	IL-10	Gene	3586
37297968	2133	2141	IL-1beta	Gene	3553
37297968	2143	2147	IL-1	Gene	3553
37297968	2149	2158	IFN-gamma	Gene	3458
37297968	2160	2164	IL-4	Gene	3565
37297968	2166	2174	TGF-beta	Gene	7040
37297968	2179	2187	cortisol	Chemical	MESH:D006854
37297968	2298	2307	lidocaine	Chemical	MESH:D008012
37297968	2328	2340	inflammatory	Disease	MESH:D007249
37297968	Association	MESH:D007249	7040
37297968	Negative_Correlation	MESH:D008012	3146
37297968	Negative_Correlation	MESH:D008012	7124
37297968	Association	MESH:D007249	3586
37297968	Negative_Correlation	MESH:D008012	MESH:D007249
37297968	Negative_Correlation	MESH:D008012	3605
37297968	Association	MESH:D007249	3557
37297968	Association	MESH:D007249	7124
37297968	Negative_Correlation	MESH:D008012	3576
37297968	Negative_Correlation	MESH:D008012	3569
37297968	Negative_Correlation	MESH:D008012	3557
37297968	Negative_Correlation	MESH:D008012	1401

